日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth

胰高血糖素样肽-1受体激动剂艾塞那肽-4和二甲双胍联合治疗可减缓乳腺癌的生长

Yuki Tanaka, Chikayo Iwaya, Takako Kawanami, Yuriko Hamaguchi, Tsuyoshi Horikawa, Toru Shigeoka, Toshihiko Yanase, Daiji Kawanami, Takashi Nomiyama

Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro

钠-葡萄糖协同转运蛋白 2 抑制剂卡格列净体外抑制肺癌细胞增殖

Leona Yamamoto, Shinichi Yamashita, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Toru Shigeoka, Tsuyoshi Horikawa, Yuki Tanaka, Toshihiko Yanase, Daiji Kawanami, Akinori Iwasaki

Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet

PPARα 激动剂 Pemafibrate 可减弱正常饮食和高脂饮食喂养的小鼠血管损伤后的新生内膜形成

Tsuyoshi Horikawa, Takako Kawanami, Yuriko Hamaguchi, Yuki Tanaka, Shotaro Kita, Ryutaro Ryorin, Yuichi Takashi, Hiroyuki Takahashi, Makito Tanabe, Toshihiko Yanase, Daiji Kawanami, Takashi Nomiyama

Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression

激活过度表达的胰高血糖素样肽-1受体可通过抑制细胞周期进程来减弱前列腺癌的生长

Toru Shigeoka, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Tsuyoshi Horikawa, Tomoko Tanaka, Shinichiro Irie, Ryoko Motonaga, Nobuya Hamanoue, Makito Tanabe, Kazuki Nabeshima, Masatoshi Tanaka, Toshihiko Yanase, Daiji Kawanami

GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells

GLP-1受体激动剂艾塞那肽-4减弱血管平滑肌细胞中NR4A孤儿核受体NOR1的表达

Hiroyuki Takahashi,Takashi Nomiyama,Yuichi Terawaki,Takako Kawanami,Yuriko Hamaguchi,Tomoko Tanaka,Makito Tanabe,Dennis Bruemmer,Toshihiko Yanase

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice

DPP-4 抑制剂利格列汀与 SGLT2 抑制剂恩格列净联合治疗可减弱糖尿病小鼠血管损伤后的新生内膜形成

Hiroyuki Takahashi, Takashi Nomiyama, Yuichi Terawaki, Takeshi Horikawa, Takako Kawanami, Yuriko Hamaguchi, Tomoko Tanaka, Ryoko Motonaga, Takashi Fukuda, Makito Tanabe, Toshihiko Yanase

Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes

选择性雄激素受体调节剂 S42 对培养的肌管具有合成代谢和抗分解代谢作用

Yoshimi Muta, Tomoko Tanaka, Yuriko Hamaguchi, Nobuya Hamanoue, Ryoko Motonaga, Makito Tanabe, Takashi Nomiyama, Hajime Nawata, Toshihiko Yanase

Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation

选择性雄激素受体调节剂 S42 抑制前列腺癌细胞增殖

Takako Kawanami, Tomoko Tanaka, Yuriko Hamaguchi, Takashi Nomiyama, Hajime Nawata, Tosihiko Yanase

Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation

Exendin-4 是一种胰高血糖素样肽-1 受体激动剂,可通过抑制 NF-κB 激活来抑制乳腺癌生长

Chikayo Iwaya, Takashi Nomiyama, Shiho Komatsu, Takako Kawanami, Yoko Tsutsumi, Yuriko Hamaguchi, Tsuyoshi Horikawa, Yasuteru Yoshinaga, Shinichi Yamashita, Tomoko Tanaka, Yuichi Terawaki, Makito Tanabe, Kazuki Nabeshima, Akinori Iwasaki, Toshihiko Yanase

Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line

芳基烃受体相互作用蛋白 (AIP) 破坏的生长激素细胞系中生长激素分泌增加和 Stat3 磷酸化

Takashi Fukuda, Tomoko Tanaka, Yuriko Hamaguchi, Takako Kawanami, Takashi Nomiyama, Toshihiko Yanase